- JP-listed companies
- TOWA PHARMACEUTICAL CO.,LTD.
TOWA PHARMACEUTICAL CO.,LTD.JP:4553
Market cap
¥150.5B
P/E ratio
9.3x
| Mar 31, 2013 | Mar 31, 2014 | Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | |
| Profit (loss) before income taxes | 9,310 | 8,702 | 15,206 | 9,903 | 7,237 | 9,833 | 18,886 | 20,709 | 18,728 | 22,246 | 4,605 | 24,459 |
| Depreciation | 4,909 | 5,407 | 5,724 | 7,329 | 7,980 | 8,173 | 8,340 | 8,285 | 9,674 | 10,153 | 14,261 | 13,659 |
| Amortization of goodwill | - | - | - | - | - | - | - | - | 751 | 801 | 5,148 | 4,229 |
| Increase (decrease) in allowance for doubtful accounts | -44 | -18 | 71 | 51 | -271 | 358 | -320 | -22 | 47 | 741 | 31 | -94 |
| Increase (decrease) in provision for bonuses for directors (and other officers) | - | 32 | - | -19 | -14 | 23 | -13 | -35 | 44 | -9 | 4 | -25 |
| Increase (decrease) in retirement benefit liability | - | -31 | -63 | 6 | 17 | 114 | 4 | 3 | 156 | -7 | -275 | -135 |
| Decrease (increase) in retirement benefit asset | - | - | - | - | - | - | - | - | -6 | 7 | 27 | - |
| Loss (gain) on sale of non-current assets | -5 | - | - | -1 | -1 | - | -2 | - | -245 | -123 | -17 | -313 |
| Loss (gain) on disposal of non-current assets | 129 | 63 | 213 | 238 | 177 | 83 | 41 | 6 | 148 | 27 | 63 | 88 |
| Interest and dividend income | -53 | -50 | -116 | -107 | -33 | -63 | -53 | -87 | -29 | -15 | -25 | -106 |
| Interest expenses | 109 | 122 | 135 | 163 | 164 | 158 | 146 | 131 | 190 | 230 | 635 | 947 |
| Loss (gain) on valuation of derivatives | -1,151 | -331 | -2,999 | 2,280 | 502 | 1,334 | -1,144 | -3,672 | 2,388 | -2,896 | 1,850 | -5,550 |
| Loss (gain) on valuation of securities | -207 | -135 | -104 | 7 | 18 | -9 | -8 | 1 | -17 | 5 | 19 | -18 |
| Decrease (increase) in trade receivables | -749 | -2,289 | -3,164 | -3,134 | -421 | -4,240 | -4,153 | 2,776 | -4,544 | 441 | -1,592 | -15,523 |
| Decrease (increase) in inventories | -2,371 | -2,963 | -7,503 | -6,913 | -2,439 | 3,192 | -1,616 | -4,301 | -9,707 | -7,950 | -18,496 | -6,288 |
| Increase (decrease) in trade payables | 1,009 | 2,319 | 2,801 | 1,543 | -1,371 | -967 | 4,659 | 1,826 | 2,451 | 3,675 | 6,554 | -10,509 |
| Subsidy income | -322 | -59 | -54 | -538 | -99 | -590 | -466 | -170 | -305 | -310 | -205 | -362 |
| Other, net | 1,214 | -491 | 767 | -1,749 | -403 | 1,451 | -1,312 | 362 | -1,752 | -235 | -3,082 | 5,630 |
| Subtotal | 11,894 | 10,297 | 10,936 | 9,040 | 11,044 | 20,626 | 22,751 | 25,800 | 17,971 | 26,782 | 9,066 | 10,087 |
| Interest and dividends received | 53 | 50 | 116 | 100 | 23 | 52 | 42 | 76 | 16 | 9 | 24 | 104 |
| Interest paid | -109 | -128 | -134 | -167 | -163 | -161 | -148 | -130 | -172 | -226 | -610 | -941 |
| Income taxes refund (paid) | - | - | - | - | - | - | - | - | - | -4,747 | -6,285 | -1,760 |
| Proceeds from compensation | - | - | - | - | - | - | - | - | - | - | 143 | 509 |
| Subsidies received | 158 | 77 | 72 | 126 | 548 | 208 | 583 | 289 | 423 | 310 | 205 | 214 |
| Net cash provided by (used in) operating activities | 8,645 | 8,144 | 8,037 | 3,732 | 10,195 | 19,230 | 19,002 | 19,164 | 12,008 | 22,129 | 2,544 | 8,212 |
| Proceeds from sale of securities | 4,000 | 6,000 | 7,500 | 11,998 | 13,999 | 19,116 | 25,999 | 12,199 | - | 18 | 34 | - |
| Purchase of property, plant and equipment | -10,524 | -7,954 | -13,321 | -13,554 | -20,488 | -14,476 | -11,143 | -4,549 | -9,137 | -11,140 | -28,731 | -37,851 |
| Proceeds from sale of property, plant and equipment | 7 | 3 | 1 | 1 | 682 | 1,522 | 36 | - | 3 | 42 | 239 | 1 |
| Purchase of intangible assets | -154 | -264 | -385 | -563 | -680 | -897 | -211 | -121 | -742 | -2,436 | -1,738 | -1,474 |
| Proceeds from sale of intangible assets | - | - | - | - | - | - | - | - | 241 | 83 | 15 | 419 |
| Purchase of investment securities | -294 | - | - | - | - | - | -99 | -245 | - | -1 | -301 | -50 |
| Purchase of shares of subsidiaries resulting in change in scope of consolidation | - | - | - | - | - | - | - | -37,614 | - | -45,405 | - | -1,570 |
| Other, net | -643 | 97 | 475 | 1,083 | -316 | 111 | 110 | 109 | 204 | -219 | 198 | 131 |
| Net cash provided by (used in) investing activities | -11,298 | -11,300 | -8,230 | -19,032 | -22,206 | -20,093 | -3,994 | -39,541 | -9,100 | -59,729 | -30,284 | -40,394 |
| Net increase (decrease) in short-term borrowings | - | - | - | - | - | - | - | 20,200 | -20,251 | 47,135 | -45,680 | -768 |
| Proceeds from long-term borrowings | 6,500 | 6,750 | 4,400 | 22,000 | 3,500 | 9,800 | 5,000 | - | 40,500 | 9,160 | 78,831 | 46,935 |
| Repayments of long-term borrowings | -2,565 | -2,937 | -2,971 | -2,505 | -2,033 | -2,681 | -4,249 | -6,396 | -6,895 | -7,181 | -8,118 | -7,607 |
| Redemption of bonds with stock acquisition rights | - | - | - | - | - | - | - | - | -10,850 | - | -4,150 | - |
| Purchase of treasury shares | - | - | - | -5,042 | - | - | - | - | - | - | - | - |
| Dividends paid | -1,233 | -1,275 | -1,275 | -1,755 | -1,558 | -1,557 | -1,559 | -2,067 | -2,166 | -2,411 | -3,100 | -2,952 |
| Repayments of lease liabilities | -6 | -6 | -4 | - | - | - | - | - | -125 | -158 | -146 | -222 |
| Other, net | - | - | - | - | - | - | - | - | - | -25 | -153 | 24 |
| Net cash provided by (used in) financing activities | 2,793 | 3,529 | 238 | 27,970 | -92 | 4,670 | -809 | 11,748 | 184 | 46,540 | 17,481 | 35,407 |
| Effect of exchange rate change on cash and cash equivalents | 46 | 251 | 487 | 648 | 689 | 591 | 943 | 689 | 761 | 975 | 1,685 | 2,167 |
| Net increase (decrease) in cash and cash equivalents | 187 | 624 | 532 | 13,318 | -11,414 | 4,399 | 15,141 | -7,938 | 3,855 | 9,915 | -8,573 | 5,393 |